Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MEDP

Medpace Holdings Inc

Oct 22 • 04:00PM ET

546.74

+1.10 0.20 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: IQV CRL INCY LH ICON CTLT KOD FATE ALLO ONC

| Held by: IJH VTI VB XMHQ VBK VXF MDY IWP IBB IJK

Scroll to Statements

Index	-	P/E	38.23	EPS (ttm)	14.30	Insider Own	19.12%	Shs Outstand	28.09M	Perf Week	6.30%
Market Cap	15.36B	Forward P/E	35.17	EPS next Y	15.55	Insider Trans	-2.97%	Shs Float	22.72M	Perf Month	10.20%
Enterprise Value	15.19B	PEG	3.55	EPS next Q	3.76	Inst Own	95.65%	Short Float	9.14%	Perf Quarter	19.98%
Income	433.00M	P/S	6.51	EPS this Y	11.26%	Inst Trans	2.84%	Short Ratio	5.36	Perf Half Y	88.18%
Sales	2.36B	P/B	52.32	EPS next Y	10.63%	ROA	22.57%	Short Interest	2.08M	Perf YTD	64.57%
Book/sh	10.45	P/C	53.83	EPS next 5Y	10.77%	ROE	73.70%	52W High	554.14 -1.34%	Perf Year	53.41%
Cash/sh	10.16	P/FCF	22.70	EPS past 3/5Y	37.94% 36.50%	ROIC	104.92%	52W Low	250.05 118.65%	Perf 3Y	241.78%
Dividend Est.	-	EV/EBITDA	28.37	Sales past 3/5Y	22.68% 19.62%	Gross Margin	29.90%	Volatility	3.12% 3.25%	Perf 5Y	332.68%
Dividend TTM	-	EV/Sales	6.44	EPS Y/Y TTM	25.30%	Oper. Margin	21.50%	ATR (14)	16.27	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.43	Sales Y/Y TTM	13.88%	Profit Margin	18.36%	RSI (14)	64.86	Recom	3.50
Dividend Gr. 3/5Y	- -	Current Ratio	0.57	EPS Q/Q	28.45%	SMA20	4.44%	Beta	1.41	Target Price	448.20
Payout	0.00%	Debt/Eq	0.41	Sales Q/Q	23.74%	SMA50	9.95%	Rel Volume	1.71	Prev Close	545.64
Employees	5900	LT Debt/Eq	0.41	Earnings	Oct 22 AMC	SMA200	46.71%	Avg Volume	387.58K	Price	546.74
IPO	Aug 11, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.20% 2.95%	Trades		Volume	773,523	Change	0.20%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight	$425
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$474
Jul-29-25	Downgrade	UBS	Neutral → Sell	$305
Jul-23-25	Downgrade	TD Cowen	Hold → Sell	$366
Jun-24-25	Initiated	Barclays	Equal Weight	$300
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold	$328
Mar-24-25	Initiated	Leerink Partners	Market Perform	$330
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral	$413 → $349
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral	$420 → $350
Sep-25-24	Downgrade	Jefferies	Buy → Hold	$415 → $345
Aug-01-24	Initiated	Truist	Hold	$415
May-29-24	Initiated	TD Cowen	Buy	$452
May-28-24	Initiated	Mizuho	Buy	$435
Apr-23-24	Upgrade	Jefferies	Hold → Buy	$340 → $450
Mar-18-24	Initiated	Deutsche Bank	Hold	$395
Feb-15-24	Upgrade	UBS	Neutral → Buy	$282 → $452
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform	$270 → $289
May-08-23	Upgrade	Guggenheim	Neutral → Buy	$252

Show Previous Ratings

Oct-22-25 07:00PM	Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike (Investor's Business Daily)
05:40PM	Medpace (MEDP) Beats Q3 Earnings and Revenue Estimates (Zacks)
05:23PM	Medpace shares soar on blowout Q3 results, solid 2025 outlook (Investing.com)
05:03PM	Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5% (StockStory)
04:43PM	Medpace: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Loading…
04:15PM	Medpace Holdings, Inc. Reports Third Quarter 2025 Results (Business Wire)
02:35PM	Medpace Holdings, Inc. (MEDP): A Bull Case Theory (Insider Monkey)
11:40AM	SOLV or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
Oct-20-25 11:08PM	Medpace (MEDP) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-17-25 10:18AM	Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? (Zacks)
Oct-16-25 06:15PM	Medpace (MEDP) Rises As Market Takes a Dip: Key Facts (Zacks)
08:19AM	Should You be Excited about Medpace Holdings' (MEDP) Prospects? (Insider Monkey)
Oct-15-25 10:00AM	Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-14-25 09:57AM	Robust Booking Growth Boosted Medpace Holdings (MEDP) in Q3 (Insider Monkey)
Oct-10-25 06:15PM	Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks) +5.22%
03:50PM	Loading…
03:50PM	Medpace and Revvity Stocks Trade Down, What You Need To Know (StockStory)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Oct-09-25 12:10PM	Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:48AM	Brookdale Posts Strong YoY Rise in September 2025 Occupancy (Zacks)
09:40AM	Is Medpace (MEDP) Outperforming Other Medical Stocks This Year? (Zacks)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Oct-07-25 12:30PM	Nyxoah Shares Rise on First U.S. Commercial Use of Genio System (Zacks)
Oct-06-25 10:16AM	ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment (Zacks)
Oct-05-25 11:32PM	Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP) (StockStory)
Oct-03-25 11:40AM	SOLV vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Oct-02-25 06:15PM	Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors (Zacks)
11:36AM	Why Medpace (MEDP) Stock Is Trading Lower Today (StockStory)
09:40AM	Nike upgraded, RH downgraded: Wall Street's top analyst calls (The Fly)
09:34AM	Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace (Investing.com)
Sep-29-25 08:07AM	HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis (Zacks)
06:15PM	Loading…
Sep-25-25 06:15PM	Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks)
12:54PM	TMDX Partners With Mercedes-Benz to Launch Organ Transport Network (Zacks)
Sep-23-25 04:05PM	Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025 (Business Wire)
01:15PM	STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System (Zacks)
01:11PM	Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now (Zacks)
Sep-22-25 12:33PM	Stryker Expands R&D Facility in India to Boost Medtech Innovation (Zacks)
12:27PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
09:09AM	Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus (Zacks)
Sep-19-25 09:19AM	Does Medpace Holdings (MEDP) Have a Long Runway For Growth? (Insider Monkey)
07:34AM	SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits (Zacks)
Sep-18-25 10:14AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
10:05AM	SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care (Zacks)
08:42AM	Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio (Zacks)
08:41AM	Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy (Zacks)
Sep-17-25 10:41AM	BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care (Zacks)
08:51AM	CAH Strengthens Distribution With New Consumer Health Logistics Hub (Zacks)
08:50AM	GEHC Expands Women's Health Portfolio With AI-Enabled Voluson (Zacks)
Sep-16-25 11:40AM	SOLV or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
10:26AM	ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5 (Zacks)
09:34AM	GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio (Zacks)
Sep-15-25 06:15PM	Why Medpace (MEDP) Outpaced the Stock Market Today (Zacks)
12:34PM	MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care (Zacks)
Sep-12-25 03:49AM	The Zacks Analyst Blog Highlights Hasbro, Robinhood Markets, Interactive Brokers, Celsius and Medpace (Zacks)
Sep-11-25 12:24PM	Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study (Zacks)
12:20PM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
09:45AM	5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025 (Zacks)
08:24AM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Sep-10-25 12:35PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
09:02AM	Dentsply Sirona Retains Wellspect Following Strategic Review (Zacks)
Sep-09-25 01:25PM	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks)
08:45AM	Lifeward Achieves European Approval for Latest ReWalk Exoskeleton (Zacks)
Sep-08-25 07:34PM	Medpace (MEDP) Outpaces Stock Market Gains: What You Should Know (Zacks)
12:36PM	Cardinal Health Expands At-Home Solutions With New Texas Facility (Zacks)
08:14AM	MYGN Stock Might Gain on The Lancet Study Backing Precise MRD (Zacks)
08:07AM	GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System (Zacks)
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
11:31AM	Medpace Holdings, Inc. (MEDP): A Bull Case Theory (Insider Monkey)
10:56AM	MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain? (Zacks)
08:06AM	Here's Why You Should Hold Cencora Stock in Your Portfolio Now (Zacks)
Sep-04-25 11:40AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
Sep-03-25 01:23PM	HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
08:50AM	STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep (Zacks)
Sep-02-25 01:32PM	IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection (Zacks)
Sep-01-25 12:53PM	GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System (Zacks)
09:54AM	ABT Stock Gains From Navitor's Expanded Indication Approval in Europe (Zacks)
09:51AM	FDA Identifies ICU Medical's Plum Duo Recall as Serious Type (Zacks)
Aug-29-25 12:24PM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
09:47AM	Here's Why You Should Add CLOV Stock to Your Portfolio Now (Zacks)
09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
Aug-28-25 11:40AM	COR vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
10:24AM	VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up (Zacks)
08:14AM	PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down (Zacks)
Aug-27-25 12:25PM	PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment (Zacks)
08:29AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
Aug-25-25 12:52PM	Natera Shares Rise on the Launch of AI Platform for Precision Oncology (Zacks)
Aug-22-25 01:30PM	BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care (Zacks)
12:03AM	2 Reasons to Watch MEDP and 1 to Stay Cautious (StockStory)
Aug-21-25 01:33PM	Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market (Zacks)
01:30PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
10:12AM	Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges (Zacks)
Aug-20-25 01:24PM	Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring (Zacks)
Aug-19-25 12:56PM	Health Care Stock Flashes Golden Cross As Sales Surge; Shares Hover Near Buy Point (Investor's Business Daily)
10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
09:48AM	MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up (Zacks)
08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
Aug-18-25 12:00PM	Medpace (MEDP) Is Up 5.41% in One Week: What You Should Know (Zacks)
Aug-15-25 10:04AM	This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine (Investor's Business Daily)
Aug-14-25 02:50PM	Tempus AI Stock Scores Relative Strength Rating Upgrade (Investor's Business Daily)
11:17AM	Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BURWIG SUSAN E	Exec. VP, Operations	Sep 26 '25	Option Exercise	107.93	10,000	1,079,300	67,500	Sep 30 04:15 PM
BURWIG SUSAN E	Exec. VP, Operations	Sep 03 '25	Sale	480.00	10,000	4,800,000	57,500	Sep 05 04:16 PM
BURWIG SUSAN E	Officer	Sep 03 '25	Proposed Sale	480.00	10,000	4,800,019		Sep 03 04:49 PM
Troendle August J.	CEO	Aug 29 '25	Sale	475.90	36,196	17,225,676	925,799	Sep 03 04:10 PM
Troendle August J.	CEO	Sep 02 '25	Sale	475.11	1,197	568,707	924,602	Sep 03 04:10 PM
Troendle August J.	CEO	Aug 27 '25	Sale	475.00	620	294,500	961,995	Aug 28 04:23 PM
BURWIG SUSAN E	Exec. VP, Operations	Aug 26 '25	Option Exercise	107.93	10,000	1,079,300	67,500	Aug 28 04:10 PM
August J. Troendle	Chairman	Aug 27 '25	Proposed Sale	475.00	38,013	18,056,018		Aug 27 05:09 PM
McCarthy Cornelius P. III	Director	Aug 19 '25	Sale	465.04	1,662	772,896	10,197	Aug 21 04:56 PM
McCarthy Cornelius P. III	Director	Aug 19 '25	Proposed Sale	465.04	1,662	772,894		Aug 19 03:00 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Jul 28 '25	Sale	450.00	3,000	1,350,000	10,343	Jul 29 06:02 PM
BURWIG SUSAN E	Exec. VP, Operations	Jul 28 '25	Sale	450.14	7,500	3,376,050	57,500	Jul 29 05:43 PM
Troendle August J.	CEO	Jul 28 '25	Sale	451.69	48,487	21,901,093	962,615	Jul 29 05:37 PM
GEIGER JESSE J	President	Jul 24 '25	Option Exercise	107.93	41,801	4,511,582	78,304	Jul 28 05:37 PM
GEIGER JESSE J	President	Jul 24 '25	Sale	453.11	41,801	18,940,451	36,503	Jul 28 05:37 PM
Brady Kevin M.	CFO & Treasurer	Jul 24 '25	Option Exercise	57.94	12,000	695,280	18,000	Jul 28 05:08 PM
Brady Kevin M.	CFO & Treasurer	Jul 24 '25	Sale	454.23	12,000	5,450,760	6,000	Jul 28 05:08 PM
BURWIG SUSAN E	Officer	Jul 28 '25	Proposed Sale	450.14	7,500	3,376,083		Jul 28 04:50 PM
August J. Troendle	Chairman	Jul 28 '25	Proposed Sale	451.68	356,446	161,001,311		Jul 28 04:35 PM
EWALD STEPHEN P	Officer	Jul 28 '25	Proposed Sale	450.00	3,000	1,350,000		Jul 28 03:27 PM
McCarthy Cornelius P. III	Director	Jul 22 '25	Option Exercise	54.99	1,972	108,440	11,859	Jul 24 04:31 PM
Brady Kevin M.	Officer	Jul 24 '25	Proposed Sale	454.23	12,000	5,450,751		Jul 24 04:13 PM
GEIGER JESSE J	Officer	Jul 24 '25	Proposed Sale	453.11	41,801	18,940,252		Jul 24 04:09 PM
McCarthy Cornelius P. III	Director	Jul 18 '25	Option Exercise	54.99	4,500	247,455	9,887	Jul 22 04:36 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Option Exercise	57.17	4,710	269,271	4,710	Apr 28 04:39 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Sale	301.82	1,712	516,716	2,998	Apr 28 04:39 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Proposed Sale	301.82	1,712	516,716		Apr 24 02:13 PM
Troendle August J.	CEO	Mar 07 '25	Option Exercise	68.62	356,446	24,458,835	1,011,102	Mar 10 05:47 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Feb 27 '25	Buy	326.11	2	652	13,343	Feb 28 04:39 PM
Carley Brian T	Director	Feb 24 '25	Option Exercise	42.62	8,127	346,373	30,035	Feb 26 04:18 PM
Carley Brian T	Director	Feb 24 '25	Sale	345.59	4,003	1,383,397	26,032	Feb 26 04:18 PM
Carley Brian T	Director	Feb 24 '25	Proposed Sale	345.59	4,003	1,383,385		Feb 24 12:52 PM
GEIGER JESSE J	President	Dec 06 '24	Option Exercise	32.05	15,000	480,750	36,503	Dec 10 04:24 PM
BURWIG SUSAN E	Exec. VP, Operations	Nov 19 '24	Option Exercise	32.05	7,500	240,375	65,000	Nov 21 04:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MEDP

Medpace Holdings Inc

Upgrade your FINVIZ experience